TY - JOUR
AU - F. B. Kropp
AU - M. C. Smid
AU - M. R. Lofwall
AU - E. M. Wachman
AU - P. R. Martin
AU - S. M. Murphy
AU - C. M. Wilder
AU - T. J. Winhusen
A1 - 
AD - Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA. Electronic address: frankie.kropp@uc.edu.;University of Utah, 50 N. Medical Drive, Salt Lake City, UT 84132, USA. Electronic address: marcela.smid@hsc.utah.edu.;Departments of Behavioral Science and Psychiatry, University of Kentucky College of Medicine, 845 Angliana Avenue, Lexington, KY 40508, USA. Electronic address: michelle.lofwall@uky.edu.;Boston Medical Center, 801 Albany Street, Boston, MA 02119, USA. Electronic address: Elisha.Wachman@bmc.org.;Vanderbilt Psychiatric Hospital, Vanderbilt University Medical Center, 1601 23rd Avenue South, Suite 3035, Nashville, TN 372124, USA. Electronic address: peter.martin@vumc.org.;Department of Population Health Sciences, Weill Cornell Medical College, 1300 York Avenue, New York, NY 10065, USA. Electronic address: smm2010@med.cornell.edu.;Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA; Center for Addiction Research, University of Cincinnati College of Medicine, 3230 Eden Avenue, Cincinnati, OH 45267, USA. Electronic address: wildercn@ucmail.uc.edu.;Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, 3131 Harvey Avenue, Cincinnati, OH 45229, USA; Center for Addiction Research, University of Cincinnati College of Medicine, 3230 Eden Avenue, Cincinnati, OH 45267, USA. Electronic address: winhust@ucmail.uc.edu.
AN - 37023858
BT - J Subst Use Addict Treat
C5 - Opioids & Substance Use;Healthcare Disparities;Measures;Education & Workforce
DA - Jun
DO - 10.1016/j.josat.2023.209030
DP - NLM
ET - 20230404
JF - J Subst Use Addict Treat
LA - eng
PY - 2023
SN - 2949-8767 (Print);2949-8759
SP - 209030
ST - Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study
T1 - Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study
T2 - J Subst Use Addict Treat
TI - Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study
U1 - Opioids & Substance Use;Healthcare Disparities;Measures;Education & Workforce
U3 - 10.1016/j.josat.2023.209030
VL - 149
VO - 2949-8767 (Print);2949-8759
Y1 - 2023
ER -